Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.1150
+0.0100 (9.52%)
At close: Feb 9, 2026
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 33.09 million as of February 9, 2026. Its market cap has increased by 114.11% in one year.
Market Cap
33.09M
Enterprise Value
153.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 33.09M, an increase of 44.23%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 33.09M | 15.06% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 52.56M |
| MedMira | 45.33M |
| BriaCell Therapeutics | 35.41M |
| Defence Therapeutics | 35.00M |
| Thiogenesis Therapeutics | 32.40M |
| Microbix Biosystems | 31.17M |
| Telescope Innovations | 29.09M |
| Devonian Health Group | 27.66M |